Latest news with #Georges-PascalHaber
Al Etihad
2 days ago
- Business
- Al Etihad
Cleveland Clinic Abu Dhabi sets new standard in cardiovascular care with AlphaVac procedure
3 June 2025 13:51 ABU DHABI (ALETIHAD)Cleveland Clinic Abu Dhabi, part of the M42 group, has successfully performed the AlphaVac thrombectomy, marking a significant milestone in advanced vascular AlphaVac device is a vacuum-assisted medical tool used to remove dangerous blood clots from the body, particularly large veins in the heart and minimally invasive, catheter-based technique helps reduce the risk of postoperative complications compared to traditional open-heart breakthrough procedure was performed by the hospital's Heart, Vascular & Thoracic Institute (HVTI) on a critically ill 70-year-old patient with multiple severe underlying health conditions, including hypertension, chronic kidney disease, heart failure, and atrial fibrillation (irregular heartbeats).The patient also had coronary artery disease and aortic valve stenosis, which is the narrowing of the heart's blood vessels and main valve, which had previously required her to undergo open-heart Georges-Pascal Haber, CEO of Cleveland Clinic Abu Dhabi, stated, 'As medical advancements rapidly accelerate, building a sustainable healthcare system requires a relentless commitment to innovation. Over the past decade, Cleveland Clinic Abu Dhabi has integrated cutting-edge technologies that improve patient outcomes and transform complex care delivery.'Dr. Houssam Younes, Department Chair, Vascular Surgery, Heart, Vascular & Thoracic Institute at Cleveland Clinic Abu Dhabi, said, "The AlphaVac offers a distinct minimally invasive advantage with its innovative nitinol basket and expandable funnel tip. It allows us to efficiently engage and remove large clot burdens with minimal blood loss."This case highlights the serious risks of lead infections and demonstrates how Cleveland Clinic Abu Dhabi is changing the landscape of high-risk cardiovascular care. Using the latest technology, the team safely removed the clot and the pacemaker, resolving the infection and ultimately helping the patient recover with minimal disruption. Source: Aletihad - Abu Dhabi
Al Etihad
28-05-2025
- Health
- Al Etihad
M42, Cleveland Clinic Abu Dhabi, Gunma University in Japan to drive innovation in heavy ion therapy for cancer treatment
28 May 2025 13:18 ABU DHABI (ALETIHAD)M42 and Cleveland Clinic Abu Dhabi, have signed a Memorandum of Cooperation (MoC) with Gunma University in Japan to accelerate research and innovation in heavy ion therapy, one of the most advanced and precise forms of radiation therapy for cancer collaboration, which took place during M42 and Cleveland Clinic Abu Dhabi's recent delegation visit to Japan, will see the three entities exchange knowledge, expertise, and research to deepen scientific understanding, and to broaden the clinical applications of heavy ion collaboration builds on M42 and Cleveland Clinic Abu Dhabi's recent partnership with Toshiba Energy Systems & Solutions Corporation (Toshiba ESS) to establish the region's first heavy ion therapy facility in Abu initiative will introduce one of the world's most innovative cancer treatment technologies to the Middle East, positioning Abu Dhabi as a centre of excellence in oncology and precision no heavy ion therapy centre within a five-hour flight of the UAE, the upcoming facility—strategically located on the Cleveland Clinic Abu Dhabi campus, adjacent to the Fatima bint Mubarak Centre, the region's first-of-its-kind comprehensive cancer centre—will enhance access to this treatment for patients across the Middle Georges-Pascal Haber, Chief Executive Officer of Cleveland Clinic Abu Dhabi, said, "At Cleveland Clinic Abu Dhabi, our vision is to bring the most advanced, evidence-based treatments to our patients, and this partnership with Gunma University exemplifies that commitment. By combining our clinical expertise with Gunma's decades of leadership in heavy ion therapy, we are not only advancing scientific knowledge but also laying the groundwork for a new era of cancer care in the region."President Ishizaki Yasuki at Gunma University, commented, "Gunma University has long been committed to advancing the science of heavy ion therapy through rigorous research and clinical innovation."He added, "Partnering with M42 will enable us to expand the reach of this transformative therapy, fostering international collaboration and ensuring that more patients worldwide benefit from the latest advancements in cancer treatment." Gunma University has been at the forefront of radiation oncology and nuclear medicine in Japan for decades. The Gunma University Heavy Ion Medical Centre (GHMC), established in 2005, has been instrumental in refining heavy ion radiotherapy by integrating radiation biology, clinical studies, and cutting-edge treatment technologies. Source: Aletihad - Abu Dhabi
Al Etihad
13-03-2025
- Health
- Al Etihad
Cleveland Clinic Abu Dhabi marks a decade of impact in healthcare transformation
SARA ALZAABI (ABU DHABI) Cleveland Clinic Abu Dhabi, part of M42 group, is celebrating its 10th anniversary of healthcare innovation and complex care, marking significant milestones with over 6.8 million patient visits and the delivery of 175,000 surgical procedures. Recognised as the leading research hospital in the UAE, it has also been instrumental in pioneering new methods of research in transplant, cardiovascular care, oncology, ophthalmology, and neurology. It is the first multi-organ transplant centre in the UAE with over 800 transplants, and it is a pioneer in robotic surgeries with more than 1,100 surgeries. Its Fatima bint Mubarak Center for cancer care has introduced precision oncology and is at the forefront of neurosurgical care, performing deep brain stimulation among more than 6,400 surgeries. In its efforts to further precision medicine and clinical research, Cleveland Clinic Abu Dhabi is harnessing AI and robotics, conducting 229 active studies. Committed to educating the next generation of healthcare professionals, the hospital has trained 90,000 professionals through the Continuing Medical Education (CME) programme and clinical placements. While continuing to contribute to Abu Dhabi's health vision and solidifying the UAE's position as an organised leader of educational excellence, Cleveland Clinic Abu Dhabi is also pioneering medical advancements and world-class care in the region. Dr. Georges-Pascal Haber, CEO of Cleveland Clinic Abu Dhabi, shared insights about the clinic's achievements and future vision in an interview with Aletihad. "In just 10 years, we have not only achieved our mission of bringing world-class care closer to home for the patients of Abu Dhabi, the UAE, and helping elevate healthcare standards in the entire region, but we have also attracted patients from abroad," he said. In terms of medical tourism, it was noted that between 2023 and 2024, there was a 35% increase in the number of patients travelling to Abu Dhabi for their care. For Dr. Haber, the role of technology, AI, and robotics in transforming healthcare is tremendous; he describes AI as transferring medicine from, "an art and science into an engineering problem", revolutionising patient care, surgery, and precision medicine. Dr. Haber stressed the importance of collaboration in the success of Cleveland Clinic Abu Dhabi, saying: "This is what turned Cleveland Clinic Abu Dhabi from a dream into reality". Highlighting advancements in the transplant field, Dr. Haber pointed to the spectacular growth of the clinic's transplant programme: "What took almost a century in any other academic medical centre to develop was achieved within just seven years here." Significant progress is made in the area of cancer treatment by the Fatima bint Mubarak Center, where the most advanced treatment approaches and new drug therapies and trials are offered. Dr. Haber also commended the centre's efforts in genomic research, noting that they are sequencing almost a million patient genomes to expedite medicine discovery. "In the next 10 years, we aim to be a leading, innovative academic medical centre focused on complex care and pioneering new healthcare techniques, including robotic surgery, AI, and precision medicine, while continuing to provide quality care and meet patient needs," he added. Speaking to Aletihad, Mansoor Ibrahim Al Mansoori, Chairman of the Department of Health – Abu Dhabi (DoH), highlighted Cleveland Clinic Abu Dhabi's contributions to the development of the DoH vision for the emirate as a premier healthcare destination. "The health of our population remains our top priority. By creating the most intelligent and efficient health system, we aim to deliver personalised and preventive solutions at scale, enabling our population to live healthier, longer and more fulfilling lives. Cleveland Clinic Abu Dhabi, along with other strategic partners, plays a vital role in the research and innovation required to develop and implement these solutions locally and globally." Also speaking to Aletihad, Hasan Jasem Al Nowais, Chairman of Cleveland Clinic Abu Dhabi, said: "Cleveland Clinic Abu Dhabi was a bold vision of President His Highness Sheikh Mohamed bin Zayed Al Nahyan. If you go back to the time when the negotiations started, people would have probably thought it impossible to build something like what has been built in Abu Dhabi. That dream has become a reality, much quicker than was anticipated. This is, of course, because of God's blessing, because of the bold vision of our leadership and the full support of people here on the ground." "I am proud and honoured to have been part of this journey, and being able to say that we have touched every patient's life who has come into this building," Al Nowais added.
The National
13-03-2025
- Health
- The National
Cleveland Clinic Abu Dhabi plans next 10 years of healthcare innovation
Cleveland Clinic Abu Dhabi is mapping out the next decade of care for residents of the UAE as well as international patients, including growing its reputation abroad and becoming a centre of excellence for robotic surgery. During its 10 years, the hospital, which is home to about 5,700 caregivers representing 80 nationalities, has treated more than 6.8 million people and carried out more than 175,000 surgical procedures. Last year alone, the hospital received more than one million patients and performed more than 26,000 surgical procedures, with more than 10,000 international patients travelling to Abu Dhabi for specialised treatment. 'It makes me feel very, very proud of what Cleveland Clinic Abu Dhabi has achieved in just 10 years,' Dr Georges-Pascal Haber, the hospital's chief executive, told The National, as he set out his plans for the next decade. 'It has been a journey of excellence, bringing complex care not only to Abu Dhabi and the UAE but to the entire region.' 'The original mission of Cleveland Clinic Abu Dhabi was to provide world-class care closer to home,' Dr Haber said, noting that many Emirati patients used to travel abroad for advanced treatment. 'Now, they can receive the same level of care – if not better – right here at home.' However, Dr Haber said the role of the hospital very quickly expanded and it became recognised as one of the top medical facilities globally, with the hospital registering a 35 per cent increase in its number of international patients over 2023 and 2024. 'It quickly became clear that the entire region was looking for top-tier medical treatment,' Dr Haber said. 'Abu Dhabi has built a strong reputation for quality and excellence, attracting patients from across the region and even globally for complex procedures such as heart surgery, neurosurgery, transplants and cancer treatment. Last year, we treated around 10,000 international patients. In the first two months of this year, we have already set new records for international patient numbers.' The hospital's chief says he is committed to maintaining the standards set by Cleveland Clinics in Ohio, Florida and London. 'I like to say that we provide the same level of care,' Dr Haber. 'Sometimes, I'm proud to say, maybe even better.' Since opening in Abu Dhabi in 2015, the hospital has executed more than 800 transplants, 550 transcatheter valve replacements and at least 6,400 neurosurgical operations. Since it was opened in 2023, the hospital's Fatima bint Mubarak Centre has recorded more than 55,000 oncology clinic visits and performed in excess of 14,000 radiation treatment sessions, about 22,000 chemotherapy infusions and 14,000 imaging studies. The hospital has also introduced the UAE's first fully robotic mastectomy and has been at the forefront of precision oncology, offering advanced genomic testing and personalised treatment plans. Cleveland Clinic Abu Dhabi is now recognised as a centre of excellence for several specialties by the Department of Health, including stroke care and cardiac surgery. Dr Haber has set his sights on achieving the same status on robotic surgery, with the hospital having performed more than 1,100 robotic surgical operations to date. 'This is an area we will be expanding further,' he said. 'I expect Cleveland Clinic Abu Dhabi to become a global centre of excellence for robotic surgery. We will pioneer new techniques and help more patients worldwide through innovations such as remote surgery.' The hospital has also been at the forefront of clinical research, with 229 active studies and a total of 600 research projects in the past decade. Cleveland Clinic Abu Dhabi still hopes to expand but Dr Haber is aware of how important the role of technology will be in the years ahead. 'As we grow, we will also leverage technology,' he said. 'The world is facing a healthcare workforce shortage and we need to adapt. With an ageing population and increasing demand for health care, we must use technology to support our caregivers while ensuring we continue delivering compassionate care.' As Cleveland Clinic Abu Dhabi enters its second decade, it is focused on shaping the future of health care, combining medical expertise with cutting-edge technology to set new global standards. 'The first 10 years have proven that we can provide high-level, world-class care,' Dr Haber said. 'I think the next 10 years will be about defining the future of health care. Here in Abu Dhabi, we will be creating that future.' Mansoor Ibrahim Al Mansouri, Chairman of the Department of Health – Abu Dhabi said: 'In Abu Dhabi, we believe that the health of our population is one of our greatest assets. Cleveland Clinic Abu Dhabi plays a pivotal role in supporting our vision to create a world-class intelligent health system. "This milestone not only highlights the hospital's role as a catalyst for innovative health care but also demonstrates how strategic collaboration can transform patient care on a global scale."
The National
13-03-2025
- Health
- The National
Cleveland Clinic Abu Dhabi plans out next 10 years of healthcare innovation
Cleveland Clinic Abu Dhabi is mapping out the next decade of care for residents of the UAE as well as international patients, including growing its reputation abroad and becoming a centre of excellence for robotic surgery. During its 10 years, the hospital, which is home to about 5,700 caregivers representing 80 nationalities, has treated more than 6.8 million people and carried out more than 175,000 surgical procedures. Last year alone, the hospital received more than one million patients and performed more than 26,000 surgical procedures, with more than 10,000 international patients travelling to Abu Dhabi for specialised treatment. 'It makes me feel very, very proud of what Cleveland Clinic Abu Dhabi has achieved in just 10 years,' Dr Georges-Pascal Haber, the hospital's chief executive, told The National, as he set out his plans for the next decade. 'It has been a journey of excellence, bringing complex care not only to Abu Dhabi and the UAE but to the entire region.' 'The original mission of Cleveland Clinic Abu Dhabi was to provide world-class care closer to home,' Dr Haber said, noting that many Emirati patients used to travel abroad for advanced treatment. 'Now, they can receive the same level of care – if not better – right here at home.' However, Dr Haber said the role of the hospital very quickly expanded and it became recognised as one of the top medical facilities globally, with the hospital registering a 35 per cent increase in its number of international patients over 2023 and 2024. 'It quickly became clear that the entire region was looking for top-tier medical treatment,' Dr Haber said. 'Abu Dhabi has built a strong reputation for quality and excellence, attracting patients from across the region and even globally for complex procedures such as heart surgery, neurosurgery, transplants and cancer treatment. Last year, we treated around 10,000 international patients. In the first two months of this year, we have already set new records for international patient numbers.' The hospital's chief says he is committed to maintaining the standards set by Cleveland Clinics in Ohio, Florida and London. 'I like to say that we provide the same level of care,' Dr Haber. 'Sometimes, I'm proud to say, maybe even better.' Since opening in Abu Dhabi in 2015, the hospital has executed more than 800 transplants, 550 transcatheter valve replacements and at least 6,400 neurosurgical operations. Since it was opened in 2023, the hospital's Fatima bint Mubarak Centre has recorded more than 55,000 oncology clinic visits and performed in excess of 14,000 radiation treatment sessions, about 22,000 chemotherapy infusions and 14,000 imaging studies. The hospital has also introduced the UAE's first fully robotic mastectomy and has been at the forefront of precision oncology, offering advanced genomic testing and personalised treatment plans. Cleveland Clinic Abu Dhabi is now recognised as a centre of excellence for several specialties by the Department of Health, including stroke care and cardiac surgery. Dr Haber has set his sights on achieving the same status on robotic surgery, with the hospital having performed more than 1,100 robotic surgical operations to date. 'This is an area we will be expanding further,' he said. 'I expect Cleveland Clinic Abu Dhabi to become a global centre of excellence for robotic surgery. We will pioneer new techniques and help more patients worldwide through innovations such as remote surgery.' The hospital has also been at the forefront of clinical research, with 229 active studies and a total of 600 research projects in the past decade. Cleveland Clinic Abu Dhabi still hopes to expand but Dr Haber is aware of how important the role of technology will be in the years ahead. 'As we grow, we will also leverage technology,' he said. 'The world is facing a healthcare workforce shortage and we need to adapt. With an ageing population and increasing demand for health care, we must use technology to support our caregivers while ensuring we continue delivering compassionate care.' As Cleveland Clinic Abu Dhabi enters its second decade, it is focused on shaping the future of health care, combining medical expertise with cutting-edge technology to set new global standards. 'The first 10 years have proven that we can provide high-level, world-class care,' Dr Haber said. 'I think the next 10 years will be about defining the future of health care. Here in Abu Dhabi, we will be creating that future.' Mansoor Ibrahim Al Mansouri, Chairman of the Department of Health – Abu Dhabi said: 'In Abu Dhabi, we believe that the health of our population is one of our greatest assets. Cleveland Clinic Abu Dhabi plays a pivotal role in supporting our vision to create a world-class intelligent health system. "This milestone not only highlights the hospital's role as a catalyst for innovative health care but also demonstrates how strategic collaboration can transform patient care on a global scale."
